Amgen Announces $650 Million Expansion of U.S. Manufacturing, Creating Nearly 750 New Jobs
Amgen Inc. has announced a $650 million expansion of its U.S. manufacturing network, which will create nearly 750 new jobs, including construction and highly skilled manufacturing roles. The investment will boost drug production at Amgen's biologics manufacturing facility in Juncos, Puerto Rico, and integrate advanced technologies into its operations. Company officials highlighted that the expansion demonstrates Amgen's commitment to strengthening U.S. biomanufacturing and supply chain resilience. Puerto Rico leaders praised the move as a sign of mutual loyalty and a boost to the island's position as a leading biopharmaceutical hub. This project builds on Amgen's ongoing investments in science, technology, and domestic manufacturing.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amgen Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA84087) on September 26, 2025, and is solely responsible for the information contained therein.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。